MannKind | MNKD - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Adma Biologics USD 4.34B 845M 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Halozyme Therapeutics USD 8.56B 905M 2026-05
Insmed USD 15.56B 19.73B 2026-05
Karyopharm Therapeutics USD 956M 821M 2026-05
MacroGenics USD 102M 4M 2025-12
MannKind USD 965M 208M 2026-05
Merck USD 297.1B 35.84B 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 147.4B 6.42B 2026-05
Sanofi EUR 100.27B 605.48M 2026-03
Xencor USD 795M 98M 2026-05